Outcome of esophageal carcinoma in the veteran affairs population: A comparative analysis from the veteran affairs central cancer registry

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 32, Issue 3, 2009, Pages 286-290

  Beg, Muhammad Shaalan ^a   Navaneethan, Udayakumar ^a   Atiq, Muslim ^b   Komrokji, Rami ^a   Safa, Malek ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Epidemiology; Esophageal carcinoma; SEER; Veteran affairs

Indexed keywords

ADENOCARCINOMA; AGE DISTRIBUTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURGERY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; ESOPHAGUS CARCINOMA; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POPULATION BASED CASE CONTROL STUDY; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TUMOR LOCALIZATION; VETERAN;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VETERANS;

EID: 67749086749     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31818af0d8     Document Type: Article

References (28)

1. El-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am. 2002;31:421-440, viii.
2. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin North Am. 2002;11:235-256.
3. Pohl H, Welch HG. The role of over diagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142-146.
4. Benhamiche AM, Faivre J, Tazi AM, et al. Time trends in diagnostic strategy, treatment, and prognosis of gastric cancer in the elderly: a population based study. Eur J Cancer Prev. 1997;6:71-77.
5. Botterweck AA, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the esophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:645-654.
6. Ekstrom AM, Signorello LB, Hansson LE, et al. Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst. 1999;91:786-790.
7. Hughes WS. Esophageal cancer. In: Everhart JE, ed. Digestive diseases in the United States: Epidemiology and impact. Washington, DC: US Dept of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1994:159-180. NIH publication 94-1447.
8. Chen MY, Ott DJ, Gelfand DW. More evidence for the increasing prevalence of adenocarcinoma of the esophagus over an 18-year period. J Clin Gastroenterol. 1995;21:254-262.
9. McKinney PA, Sharp L, MacFarlane GJ, et al. Esophageal and gastric cancer in Scotland 1960-90. Br J Cancer. 1994;63:412-415.
10. Pera M, Cameron AJ, Trastek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104: 510-513.
11. Yang PC, Davis S. Incidence of cancer of the esophagus in the US by histologic type. Cancer. 1988;92:612-617.
12. Cameron AJ, Kamath PS, Carpenter HC. Barrett's esophagus, the prevalence of short and long segments in reflux patients. Gastroenterology. 1995;108:A65 [abstract].
13. Williamson WA, Ellis FH Jr, Gibb SP, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med. 1991;151:2212-2216.
14. Blot WJ, Devesa SS, Fraumeni JF Jr. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA. 1993;270:1320.
15. Chalasani N, Wo JM, Waring JP. Racial differences in the histology, location and risk factors of esophageal cancer. J Clin Gastroenterol. 1998;26:11-13.
16. Chow WH, Finkle WD, McLaughlin JK, et al. The relation of gastroesoph-ageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA. 1995;274:474-477.
17. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831.
18. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999; 130:883-890.
19. Schlansky B, Dimarino AJ Jr, Loren D, et al. A survey of esophageal cancer: pathology, stage and clinical presentation. Aliment Pharmacol Ther. 2006;23: 587-593.
20. Van Dam J, Brugge WR. Endoscopy of the upper gastrointestinal tract. N Engl J Med. 1999;341:1738-1748.
21. Enzinger PC, Mayer RJ. Medical progress: esophageal cancer. N Engl J Med. 2003;349:2241-2252.
22. Eloubeidi MA, Mason AC, Desmond RA, et al. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope? Am J Gastroenterol. 2003;98:1627-1633.
23. Whooley BP, Law S, Murthy SC, et al. Analysis of reduced death and complication rates after esophageal resection. Ann Surg. 2001;233:338-344.
24. Howe HL, Wu X, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006;107:1711-1742.
25. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
26. Stein HJ, Feith M, Bruecher BL, et al. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005;242:566-573; discussion 573-575.
27. Mariette C, Finzi L, Piessen G, et al. Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. World J Surg. 2005;29:39-45.
28. Greenstein AJ, Litle VR, Swanson SJ, et al. Racial disparities in esophageal cancer treatment and outcomes. Ann Surg Oncol. 2008;15:881-888.